04/23/2024
3:20 PM | Mirum Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
3:21 PM | Mirum Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024
7:47 PM | BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:41 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:44 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:46 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:34 PM | BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/18/2024
4:37 PM | Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:40 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:32 PM | Mirum Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/15/2024
4:03 PM | Mirum Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
3:05 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
11:49 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024
8:04 PM | Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:05 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:10 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:12 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:28 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
| Form SC 13G | |
01/25/2024
6:10 PM | Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:10 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:10 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:10 PM | BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:10 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:10 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
6:39 PM | Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
6:42 PM | Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:21 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:25 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:28 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:09 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:12 PM | Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
4:16 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:14 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:11 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:13 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:15 PM | Mirum Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2023
3:39 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
3:47 PM | Mirum Pharmaceuticals (Filer)
| Form S-3ASR | |
10/13/2023
3:16 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space. Click to read |
09/18/2023
3:35 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Mirum Pharmaceuticals (Subject)
| Form SC 13G | |
09/15/2023
3:56 PM | Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
6:33 PM | GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:06 PM | GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:39 PM | Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
5:21 PM | BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2023
5:23 PM | BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:16 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
4:25 PM | Mirum Pharmaceuticals (Subject)
O'Donnell Niall (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
2:11 PM | Frazier Life Sciences IX, L.P. (Filed by)
Mirum Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/05/2023
11:51 AM | Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
7:36 AM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:15 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
3:30 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:16 AM | Mirum Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023
7:16 AM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
6:47 PM | Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:30 PM | Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:33 PM | Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:35 PM | Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:37 PM | Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
1:32 PM | Mirum Pharmaceuticals (Subject)
New Enterprise Associates 16, L.P. (Filed by)
| Form SC 13D/A | |
06/15/2023
3:31 PM | Florence Anthony A. Jr. (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:34 PM | Makhzoumi Mohamad (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:35 PM | Mirum Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:36 PM | Mirum Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:22 PM | Mirum Pharmaceuticals (Issuer)
New Enterprise Associates 16, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:24 PM | Mirum Pharmaceuticals (Issuer)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:26 PM | BASKETT FOREST (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | Behbahani Ali (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | Chang Carmen (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:54 PM | Mirum Pharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:56 PM | Cardon Lon (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:00 PM | Mirum Pharmaceuticals (Issuer)
Walbert Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:40 PM | Fischer Laurent (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:45 PM | Brege Laura (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:47 PM | Fairey William (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:35 PM | GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:38 PM | Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:02 PM | Mirum Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
4:37 PM | GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
